A new weight loss drug that's being trialled as a daily pill and could rival Ozempic has delivered some astonishing results.

The pecking order of the obesity drug market is shifting. Eli Lilly , the $815 billion maker of blockbuster weight-loss drugs ...

The drug company Eli Lilly is suing four telehealth companies for allegedly selling copies made by compounding pharmacies of ...

If you're one of the many people who have been interested in Ozempic-style weight loss medications but are terrified of ...

A daily pill could be as effective for weight loss as popular drugs like Wegovy and Ozempic, providing an alternative to the ...

This is going to change the world,” Dr. Nicholas Perricone, a renowned nutritionist and dermatologist, told The Post.

Eli Lilly ( LLY 0.89%) has been growing its sales at a good clip over the past year. This is partly thanks to Zepbound, a ...

A recent medical trial could help deliver the first daily weight loss pill capable of cutting down obesity as effectively as ...

Mangoceuticals Inc. (NASDAQ:MGRX) is on a mission to rewrite the playbook for men’s performance, health, and vitality. Its pursuit comes at a time when opportunities have become enormous, with patent ...

A significant trial of a daily weight-loss pill has found that it helped people to shed the pounds and reduce their blood ...

Burnjaro stands out in the weight loss supplement industry due to its science-backed ingredients, clean manufacturing process ...

But this one, for Lilly’s first diabetes and weight-loss pill based on the GLP-1 hormone, was particularly fraught. Days ...